Pharma lobbying for weight loss drugs could soon pay off

Novo Nordisk has spent millions of dollars over a decade lobbying for obesity drugs to be covered by Medicare. It could soon happen.

Related Keywords

United Kingdom ,United States ,Philadelphia ,Pennsylvania ,Miami ,Florida ,New Jersey ,Americans ,Katherine Hempstead ,Herb Conaway ,Stephen Klasko ,Eli Lilly ,Angela Fitch ,Khrysta Baig ,Obesity Medicine Association ,Vanderbilt University ,Yahoo ,Obesity Action Coalition ,Purdue Pharma ,Robert Wood Johnson Foundation ,Novo Nordisk ,Arnold Porter ,Ron Kind ,Jersey Assemblyman Herb Conaway ,Yahoo Finance ,Medicare Part ,General Catalyst ,Weight Watcher ,Jones Simmer ,Weight Loss ,Medicare ,Lobbying ,Diabetes Drugs ,Prescription Drugs ,